AIM ImmunoTech
AIM
#10626
Rank
A$3.65 M
Marketcap
A$0.87
Share price
8.45%
Change (1 day)
-95.83%
Change (1 year)

Earnings for AIM ImmunoTech (AIM)

Earnings in 2025 (TTM): -A$24.75 Million

According to AIM ImmunoTech 's latest financial reports the company's current earnings are A$0.11 Million. In 2024 the company made an earning of -A$25.14 Million, an increase over its 2023 earnings that were of -A$42.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AIM ImmunoTech from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$24.75 Million-1.55%
2024 -A$25.14 Million-40.2%
2023 -A$42.03 Million48.94%
2022 -A$28.22 Million1.66%
2021 -A$27.76 Million32.66%
2020 -A$20.93 Million51.18%
2019 -A$13.85 Million-2.81%
2018 -A$14.25 Million18.82%
2017 -A$11.99 Million10.09%
2016 -A$10.89 Million-50.74%
2015 -A$22.11 Million-12.72%
2014 -A$25.33 Million7.55%
2013 -A$23.55 Million-6.51%
2012 -A$25.19 Million21.22%
2011 -A$20.78 Million-7.56%
2010 -A$22.48 Million16.76%
2009 -A$19.25 Million3.54%
2008 -A$18.6 Million-33.58%
2007 -A$28 Million3.18%
2006 -A$27.14 Million89.3%
2005 -A$14.34 Million-9.31%
2004 -A$15.81 Million50.17%
2003 -A$10.53 Million9.55%
2002 -A$9.61 Million-24.79%
2001 -A$12.78 Million-2.66%
2000 -A$13.13 Million-6.78%
1999 -A$14.08 Million40.58%
1998 -A$10.02 Million6.15%
1997 -A$9.44 Million41.3%
1996 -A$6.68 Million360%
1995 -A$1.46 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.24 Billion 912.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$26.35 Million 15.28%๐Ÿ‡บ๐Ÿ‡ธ USA